No abstract available
MeSH terms
-
Adalimumab
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Arthritis, Rheumatoid / complications
-
Arthritis, Rheumatoid / drug therapy
-
Child
-
Child, Preschool
-
Crohn Disease / complications
-
Crohn Disease / drug therapy
-
Databases, Factual
-
Etanercept
-
Female
-
Humans
-
Immunoglobulin G / adverse effects
-
Immunoglobulin G / therapeutic use
-
Infant
-
Infliximab
-
Leukemia / chemically induced*
-
Leukemia / epidemiology*
-
Male
-
Middle Aged
-
Product Surveillance, Postmarketing
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Adalimumab
-
Etanercept